Feeling cold while taking GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)the latter being a dual GIP/GLP-1 receptor agonistis something many patients report anecdotally, though it is not listed as an official adverse effect in FDA-approved labeling for these medications
Body composition optimization in incretin therapy
For the first time, large numbers of patients are achieving sustained, clinically-significant weight loss, often 15 to 20 per cent of body weight in under a year
Motherhood is a profound identity shift, and it is natural to long for a sense of familiarity and control
For our New Orleans clients, this translates to a feeling of control they haven't experienced before
Each persons experience is unique